申请人:Dr. Karl Thomae GmbH
公开号:US05135932A1
公开(公告)日:1992-08-04
The invention relates to new 2-hydroxy-n-propylamines of the formula R.sub.1 --O--CH.sub.2 --CHOH--CH.sub.2 --NH--A--R.sub.2 (I) wherein R.sub.1, R.sub.2 and A are defined as in claim 1, the tautomers, enantiomers and acid addition salts thereof, particularly for pharmaceutical use the physiologically acceptable acid addition salts thereof with inorganic or organic acids, which have valuable pharmacological properties, more particularly a simultaneous cardiotonic and .beta.-blocking activity, and the use thereof as pharmaceutical compositions and processes for preparing them.
该发明涉及新的2-羟基-n-丙基胺,其化学式为R.sub.1 --O--CH.sub.2 --CHOH--CH.sub.2 --NH--A--R.sub.2 (I),其中R.sub.1、R.sub.2和A如权利要求书中所定义,其互变异构体、对映体和酸盐,特别用于制药用途,其与无机或有机酸形成的生理学上可接受的酸盐,具有有价值的药理学性质,更具体地具有同时心力增强和β-阻滞活性,以及将其用作制药组合物和制备它们的方法。